Submission of Intimation of Confirmation of director appointment in EGM.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals (formerly Trimurthi Limited) has confirmed that shareholders approved the appointment of Ms. Sridevi Belide (DIN: 10455373) as a Non-Executive Non-Independent Director at the Extra-Ordinary General Meeting held on 09 January 2026. The effective date of appointment is 23 October 2025. Ms. Belide is a medical professional (MBBS degree) and belongs to the company's promoter group, though she is not related to any existing director. The filing is a correction to an earlier submission dated 10 January 2026 that contained an incorrect brief profile.
This is a routine governance update with no direct impact on financials or operations. The appointment strengthens board representation, with the new director adding healthcare expertise. Shareholders should note promoter-group representation on the board has increased.